What are the major opportunities in the Lung Cancer Liquid Biopsy market? What are the strategies for the Lung Cancer Liquid Biopsy market?

For detailed insights on the major opportunities and strategies in the Lung Cancer Liquid Biopsy market, Read More

How does the Lung Cancer Liquid Biopsy market relate to the overall economy and other similar markets?

For detailed insights on Lung Cancer Liquid Biopsy's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Lung Cancer Liquid Biopsy market growth? SWOT analysis of the Lung Cancer Liquid Biopsy market.

For detailed insights on the key dynamics influencing the Lung Cancer Liquid Biopsy market growth and SWOT analysis of the Lung Cancer Liquid Biopsy industry, Read More

Global Lung Cancer Liquid Biopsy Market Report 2025

Item added to cart!

Published : December 2025

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Lung Cancer Liquid Biopsy Global Market Report 2025

Name: Lung Cancer Liquid Biopsy Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product (Instruments, Sconsumables Kits And Reagents, Software And Services), By Technology (Multi Gene-Parallel Analysis (Ngs), Single Gene Analysis (Pcr Microarrays)), By Biomarker (Cell-Free Deoxyribonucleic Acid, Circulating Tumor Deoxyribonucleic Acid, Extracellular Vesicles, Circulating Tumor Cells, Other Biomarkers), By Clinical Application (Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring, Other Applications), By End User (Diagnostics And Imaging Centres, Hospitals, Academics And Research Centres, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Lung Cancer Liquid Biopsy Market?

Lung cancer liquid biopsy is a non-invasive technique that analyzes blood or other body fluids to detect tumor-derived genetic material or cells. It enables early diagnosis, genetic profiling, and monitoring of lung cancer by capturing cancer-specific biomarkers, offering an alternative to surgical tissue biopsies.

The various lung cancer liquid biopsy products include instruments, consumables kits and reagents, and software and services. Instruments refers to the hardware and analytical devices used to process and analyze liquid biopsy samples. The technology involves multi-gene parallel analysis, such as next-generation sequencing (NGS), and single-gene analysis methods, such as PCR and microarrays. The various biomarkers include cell-free DNA, circulating tumor DNA, extracellular vesicles, circulating tumor cells, and other related markers, used in applications such as therapy selection, treatment monitoring, early cancer screening, recurrence monitoring, and other uses. The various end-users consist of diagnostic and imaging centers, hospitals, academic and research institutions, as well as other user groups.

Lung Cancer Liquid Biopsy Market Size and growth rate 2025 to 2029: Graph

What Is The Lung Cancer Liquid Biopsy Market Size 2025 And Growth Rate?

The lung cancer liquid biopsy market size has grown rapidly in recent years. It will grow from $0.95 billion in 2024 to $1.12 billion in 2025 at a compound annual growth rate (CAGR) of 17.0%. The growth in the historic period can be attributed to growing prevalence of smoking and pollution-related lung disorders, increasing applications of liquid biopsy in treatment monitoring, rising investment in oncology research and development, rising demand for rapid and cost-effective diagnostics, and rising number of clinical trials.

What Is The Lung Cancer Liquid Biopsy Market Growth Forecast?

The lung cancer liquid biopsy market size is expected to see rapid growth in the next few years. It will grow to $2.08 billion in 2029 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing incidence of lung cancer, rising demand for non-invasive diagnostic techniques, growing adoption of personalized medicine, increasing awareness about early cancer detection, and rising geriatric population susceptible to cancer. Major trends in forecast period includes advancements in circulating tumor dna (ctdna) analysis technologies, technological developments in exosome-based liquid biopsy, advancements in microfluidics for isolating circulating tumor cells, integration of ai and machine learning for biomarker interpretation, and technological innovations enabling multiplex biomarker analysis.

Book your 30 minutes free consultation with our research experts

How Is The Lung Cancer Liquid Biopsy Market Segmented?

The lung cancer liquid biopsy market covered in this report is segmented –

1) By Product: Instruments, Sconsumables Kits And Reagents, Software And Services

2) By Technology: Multi Gene-Parallel Analysis (Ngs), Single Gene Analysis (Pcr Microarrays)

3) By Biomarker: Cell-Free Deoxyribonucleic Acid, Circulating Tumor Deoxyribonucleic Acid, Extracellular Vesicles, Circulating Tumor Cells, Other Biomarkers

4) By Clinical Application: Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring, Other Applications

5) By End User: Diagnostics And Imaging Centres, Hospitals, Academics And Research Centres, Other End Users

Subsegments:

1) By Instruments: Pcr Instruments, Microarray Instruments, Next-Generation Sequencing (Ngs) Instruments

2) By Consumables Kits And Reagents: Sample Collection Kits, Amplification Reagents, sequencing reagents

3) By Software And Services: Data Analysis Software, Cloud-Based Services, Bioinformatics Tools

What Is Driving The Lung Cancer Liquid Biopsy Market? Surge In Lung Cancer Cases Fuels Growth Of Market Due To Demand For Early Detection And Personalized Treatment

The increasing incidence of lung cancer is expected to propel the growth of the lung cancer liquid biopsy market going forward. Lung cancer is a disease characterized by the uncontrolled growth of abnormal cells in the lungs, often caused by smoking and environmental exposures. Lung cancer is increasing mainly due to continued tobacco use, as smoking exposes lungs to carcinogens that trigger abnormal cell growth. Lung cancer liquid biopsy helps by detecting cancer-related genetic mutations and tumor DNA from a blood sample, enabling early diagnosis, treatment selection, and monitoring of disease progression or response to therapy. For instance, in 2023, according to the The American Cancer Society (cancer.org), a non-profit organization dedicated to ending cancer, as of January 1, 2022, 654,620 people in the U.S. had a history of lung cancer, with many living with metastatic disease. About 80% were aged 65+, and 55% were diagnosed within the past five years due to low survival rates. Therefore, the increasing incidence of lung cancer is driving the growth of the lung cancer liquid biopsy market.

Who Are The Major Players In The Global Lung Cancer Liquid Biopsy Market?

Major companies operating in the lung cancer liquid biopsy market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Biocept Inc., Agilent Technologies Inc., Eurofins Scientific, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corp, Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Guardant Health Inc., MDxHealth SA, Exosome Diagnostics Inc., Menarini Silicon Biosystems S.p.A., Inivata Ltd, Lucence Diagnostics Pte Ltd, LungLife AI Inc., Biodesix Inc., Oncocyte Corporation

What Are The Key Trends Of The Global Lung Cancer Liquid Biopsy Market? Technological Advancements In Blood-Based Lung Cancer Screening Drive Early Detection Efforts

Major companies operating in the lung cancer liquid biopsy market are focusing on developing technological advancements, such as blood-based lung cancer screening tests, to enhance early detection capabilities, improve diagnostic accuracy, and enable non-invasive, real-time monitoring of tumor progression and treatment response. A blood-based lung cancer screening test is a non-invasive approach that analyzes biomarkers in the bloodstream to identify the presence of lung cancer at an early stage. For instance, in October 2023, DELFI Diagnostics Inc., a US-based biotechnology company, launched a FirstLook Lung, a blood-based liquid biopsy test designed to aid in early lung cancer detection. That leverages fragmentomics to detect early lung cancer with high sensitivity and a 99.8% negative predictive value, making it a convenient and accessible first step for at-risk individuals. Its purpose is to improve early detection, increase screening rates, and help direct further imaging resources to those most likely to benefit.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Lung Cancer Liquid Biopsy Market? Veracyte Enhances Liquid Biopsy Capabilities Through C2i Genomics Deal

In February 2024, Veracyte Inc., a US-based molecular diagnostics company, acquired C2i Genomics Inc. for an undisclosed amount. With this acquisition, Veracyte aims to enhance its cancer diagnostics by adding advanced whole-genome MRD liquid biopsy capabilities for improved detection and monitoring across multiple cancer types. C2i Genomics Inc. is a US-based company specializing in cancer detection and monitoring that offers lung cancer biopsy tests.

What Is The Regional Outlook For The Global Lung Cancer Liquid Biopsy Market?

North America was the largest region in the lung cancer liquid biopsy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lung cancer liquid biopsy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lung cancer liquid biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Lung Cancer Liquid Biopsy Market?

The lung cancer liquid biopsy market consists of revenues earned by entities by providing services such as mutation detection and genomic profiling, treatment monitoring, and early diagnosis and screening. The market value includes the value of related goods sold by the service provider or included within the service offering. The lung cancer liquid biopsy market also includes sales of NGS-based assays, CTC detection devices and others. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Lung Cancer Liquid Biopsy Industry?

The lung cancer liquid biopsy market research report is one of a series of new reports from The Business Research Company that provides lung cancer liquid biopsy market statistics, including the lung cancer liquid biopsy industry's global market size, regional shares, competitors with the lung cancer liquid biopsy market share, detailed lung cancer liquid biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the lung cancer liquid biopsy market. This lung cancer liquid biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Author : Abdul Wasay

Lung Cancer Liquid Biopsy Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.12 billion
Revenue Forecast In 2034	$2.08 billion
Growth Rate	CAGR of 16.8% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The lung cancer liquid biopsy market covered in this report is segmented – 1) By Product: Instruments, Sconsumables Kits And Reagents, Software And Services 2) By Technology: Multi Gene-Parallel Analysis (Ngs), Single Gene Analysis (Pcr Microarrays) 3) By Biomarker: Cell-Free Deoxyribonucleic Acid, Circulating Tumor Deoxyribonucleic Acid, Extracellular Vesicles, Circulating Tumor Cells, Other Biomarkers 4) By Clinical Application: Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring, Other Applications 5) By End User: Diagnostics And Imaging Centres, Hospitals, Academics And Research Centres, Other End Users Subsegments: 1) By Instruments: Pcr Instruments, Microarray Instruments, Next-Generation Sequencing (Ngs) Instruments 2) By Consumables Kits And Reagents: Sample Collection Kits, Amplification Reagents, Sequencing Reagents 3) By Software And Services: Data Analysis Software, Cloud-Based Services, Bioinformatics Tools
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Biocept Inc., Agilent Technologies Inc., Eurofins Scientific, Illumina Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Exact Sciences Corp, Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Guardant Health Inc., MDxHealth SA, Exosome Diagnostics Inc., Menarini Silicon Biosystems S.p.A., Inivata Ltd, Lucence Diagnostics Pte Ltd, LungLife AI Inc., Biodesix Inc., Oncocyte Corporation
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Lung Cancer Liquid Biopsy Market Characteristics

3. Lung Cancer Liquid Biopsy Market Trends And Strategies

4. Lung Cancer Liquid Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Lung Cancer Liquid Biopsy Growth Analysis And Strategic Analysis Framework

5.1. Global Lung Cancer Liquid Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Lung Cancer Liquid Biopsy Market Growth Rate Analysis

5.4. Global Lung Cancer Liquid Biopsy Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Lung Cancer Liquid Biopsy Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Lung Cancer Liquid Biopsy Total Addressable Market (TAM)

6. Lung Cancer Liquid Biopsy Market Segmentation

6.1. Global Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Instruments

Sconsumables Kits And Reagents

Software And Services

6.2. Global Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Multi Gene-Parallel Analysis (Ngs)

Single Gene Analysis (Pcr Microarrays)

6.3. Global Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Cell-Free Deoxyribonucleic Acid

Circulating Tumor Deoxyribonucleic Acid

Extracellular Vesicles

Circulating Tumor Cells

Other Biomarkers

6.4. Global Lung Cancer Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Therapy Selection

Treatment Monitoring

Early Cancer Screening

Recurrence Monitoring

Other Applications

6.5. Global Lung Cancer Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostics And Imaging Centres

Hospitals

Academics And Research Centres

Other End Users

6.6. Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pcr Instruments

Microarray Instruments

Next-Generation Sequencing (Ngs) Instruments

6.7. Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Consumables Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Sample Collection Kits

Amplification Reagents

Sequencing Reagents

6.8. Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Data Analysis Software

Cloud-Based Services

Bioinformatics Tools

7. Lung Cancer Liquid Biopsy Market Regional And Country Analysis

7.1. Global Lung Cancer Liquid Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Lung Cancer Liquid Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Lung Cancer Liquid Biopsy Market

8.1. Asia-Pacific Lung Cancer Liquid Biopsy Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Lung Cancer Liquid Biopsy Market

9.1. China Lung Cancer Liquid Biopsy Market Overview

9.2. China Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Lung Cancer Liquid Biopsy Market

10.1. India Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Lung Cancer Liquid Biopsy Market

11.1. Japan Lung Cancer Liquid Biopsy Market Overview

11.2. Japan Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Lung Cancer Liquid Biopsy Market

12.1. Australia Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Lung Cancer Liquid Biopsy Market

13.1. Indonesia Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Lung Cancer Liquid Biopsy Market

14.1. South Korea Lung Cancer Liquid Biopsy Market Overview

14.2. South Korea Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Lung Cancer Liquid Biopsy Market

15.1. Western Europe Lung Cancer Liquid Biopsy Market Overview

15.2. Western Europe Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Lung Cancer Liquid Biopsy Market

16.1. UK Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Lung Cancer Liquid Biopsy Market

17.1. Germany Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Lung Cancer Liquid Biopsy Market

18.1. France Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Lung Cancer Liquid Biopsy Market

19.1. Italy Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Lung Cancer Liquid Biopsy Market

20.1. Spain Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Lung Cancer Liquid Biopsy Market

21.1. Eastern Europe Lung Cancer Liquid Biopsy Market Overview

21.2. Eastern Europe Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Lung Cancer Liquid Biopsy Market

22.1. Russia Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Lung Cancer Liquid Biopsy Market

23.1. North America Lung Cancer Liquid Biopsy Market Overview

23.2. North America Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Lung Cancer Liquid Biopsy Market

24.1. USA Lung Cancer Liquid Biopsy Market Overview

24.2. USA Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Lung Cancer Liquid Biopsy Market

25.1. Canada Lung Cancer Liquid Biopsy Market Overview

25.2. Canada Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Lung Cancer Liquid Biopsy Market

26.1. South America Lung Cancer Liquid Biopsy Market Overview

26.2. South America Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Lung Cancer Liquid Biopsy Market

27.1. Brazil Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Lung Cancer Liquid Biopsy Market

28.1. Middle East Lung Cancer Liquid Biopsy Market Overview

28.2. Middle East Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Lung Cancer Liquid Biopsy Market

29.1. Africa Lung Cancer Liquid Biopsy Market Overview

29.2. Africa Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Lung Cancer Liquid Biopsy Market Competitive Landscape And Company Profiles

30.1. Lung Cancer Liquid Biopsy Market Competitive Landscape

30.2. Lung Cancer Liquid Biopsy Market Company Profiles

30.2.1. F. Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Biocept Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis

31. Lung Cancer Liquid Biopsy Market Other Major And Innovative Companies

31.1. Illumina Inc.

31.2. Sysmex Corporation

31.3. Bio-Rad Laboratories Inc.

31.4. QIAGEN N.V.

31.5. Exact Sciences Corp

31.6. Natera Inc.

31.7. Myriad Genetics Inc.

31.8. NeoGenomics Laboratories Inc.

31.9. Guardant Health Inc.

31.10. MDxHealth SA

31.11. Exosome Diagnostics Inc.

31.12. Menarini Silicon Biosystems S.p.A.

31.13. Inivata Ltd

31.14. Lucence Diagnostics Pte Ltd

31.15. LungLife AI Inc.

32. Global Lung Cancer Liquid Biopsy Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Lung Cancer Liquid Biopsy Market

34. Recent Developments In The Lung Cancer Liquid Biopsy Market

35. Lung Cancer Liquid Biopsy Market High Potential Countries, Segments and Strategies

35.1 Lung Cancer Liquid Biopsy Market In 2029 - Countries Offering Most New Opportunities

35.2 Lung Cancer Liquid Biopsy Market In 2029 - Segments Offering Most New Opportunities

35.3 Lung Cancer Liquid Biopsy Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Lung Cancer Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Lung Cancer Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Consumables Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Lung Cancer Liquid Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Lung Cancer Liquid Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: F. Hoffmann-La Roche Ltd Financial Performance

Table 80: Thermo Fisher Scientific Inc. Financial Performance

Table 81: Biocept Inc. Financial Performance

Table 82: Agilent Technologies Inc. Financial Performance

Table 83: Eurofins Scientific Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Lung Cancer Liquid Biopsy Market, Segmentation By Clinical Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Lung Cancer Liquid Biopsy Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Consumables Kits And Reagents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Lung Cancer Liquid Biopsy Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Lung Cancer Liquid Biopsy Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Lung Cancer Liquid Biopsy Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Lung Cancer Liquid Biopsy Market, Segmentation By Biomarker, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: F. Hoffmann-La Roche Ltd Financial Performance

Figure 80: Thermo Fisher Scientific Inc. Financial Performance

Figure 81: Biocept Inc. Financial Performance

Figure 82: Agilent Technologies Inc. Financial Performance

Figure 83: Eurofins Scientific Financial Performance

Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore strategic insights and forecasts in the global virtual nutrition coach app market, offering competitive benchmarking and market growth trends.

Explore the latest trends, growth insights, and forecasts in the Key Trend Shaping The Ophthalmology Medical Service Market.

Lung Cancer Diagnostic And Screening Global Market Report 2025 – By Product (Instruments, Consumables And Accessories), By Test (Biomarkers Tests, Imaging Test, Biopsy, Blood Test, Other Tests), By Cancer Type (Non-Small...

Liquid Biopsy Global Market Report 2025 – By Product (Assays Kits, Instruments, Services), By Clinical Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring Orthopedics), By ...

Lung Cancer Drugs Global Market Report 2025 – By Drugs (Gemzar, Paraplatin, Taxotere, Navelbine, Avastin, Tarceva, Iressa, Other Drugs), By Disease Type (Small cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC))...

Cancer Diagnostics Global Market Report 2025 – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast Cancer, Li...

Small Cell Lung Cancer Therapeutics Global Market Report 2025 – By Drug Type (Atezolizumab, Topotecan, Lurbinectedin, Durvalumab, Methotrexate, Pembrolizumab), By Treatment Type (Chemotherapy, Targeted Therapy, Other Tre...

Pulmonary Drug Delivery Devices Global Market Report 2025 – By Product Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), By Application (Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other ...

Clinical Oncology Next Generation Sequencing Global Market Report 2025 – By Technology (Ion Semiconductor Sequencing, Pyro-Sequencing, Synthesis Sequencing, Real Time Sequencing, Ligation Sequencing, Reversible Dye Termi...

Frequently Asked Questions

What is the definition of the Lung Cancer Liquid Biopsy market?

How will the Lung Cancer Liquid Biopsy market drivers and restraints affect the market dynamics? What forces will shape the Lung Cancer Liquid Biopsy industry going forward?

The Lung Cancer Liquid Biopsy market major growth driver - Surge In Lung Cancer Cases Fuels Growth Of Market Due To Demand For Early Detection And Personalized Treatment. For further insights on the Lung Cancer Liquid Biopsy market, request a sample here

What is the forecast market size or the forecast market value of the Lung Cancer Liquid Biopsy market?

The Lung Cancer Liquid Biopsy market size has grown strongly in recent years. The lung cancer liquid biopsy market size has grown rapidly in recent years. It will grow from $0.95 billion in 2024 to $1.12 billion in 2025 at a compound annual growth rate (CAGR) of 17.0%. The growth in the historic period can be attributed to growing prevalence of smoking and pollution-related lung disorders, increasing applications of liquid biopsy in treatment monitoring, rising investment in oncology research and development, rising demand for rapid and cost-effective diagnostics, and rising number of clinical trials. The lung cancer liquid biopsy market size is expected to see rapid growth in the next few years. It will grow to $2.08 billion in 2029 at a compound annual growth rate (CAGR) of 16.8%. The growth in the forecast period can be attributed to increasing incidence of lung cancer, rising demand for non-invasive diagnostic techniques, growing adoption of personalized medicine, increasing awareness about early cancer detection, and rising geriatric population susceptible to cancer. Major trends in forecast period includes advancements in circulating tumor dna (ctdna) analysis technologies, technological developments in exosome-based liquid biopsy, advancements in microfluidics for isolating circulating tumor cells, integration of ai and machine learning for biomarker interpretation, and technological innovations enabling multiplex biomarker analysis. For further insights on the Lung Cancer Liquid Biopsy market, request a sample here

How is the Lung Cancer Liquid Biopsy market segmented?

The lung cancer liquid biopsy market covered in this report is segmented –
1) By Product: Instruments, Sconsumables Kits And Reagents, Software And Services
2) By Technology: Multi Gene-Parallel Analysis (Ngs), Single Gene Analysis (Pcr Microarrays)
3) By Biomarker: Cell-Free Deoxyribonucleic Acid, Circulating Tumor Deoxyribonucleic Acid, Extracellular Vesicles, Circulating Tumor Cells, Other Biomarkers
4) By Clinical Application: Therapy Selection, Treatment Monitoring, Early Cancer Screening, Recurrence Monitoring, Other Applications
5) By End User: Diagnostics And Imaging Centres, Hospitals, Academics And Research Centres, Other End Users

Subsegments:
1) By Instruments: Pcr Instruments, Microarray Instruments, Next-Generation Sequencing (Ngs) Instruments
2) By Consumables Kits And Reagents: Sample Collection Kits, Amplification Reagents, Sequencing Reagents
3) By Software And Services: Data Analysis Software, Cloud-Based Services, Bioinformatics Tools For further insights on the Lung Cancer Liquid Biopsy market, request a sample here

Which region has the largest share of the Lung Cancer Liquid Biopsy market? What are the other regions covered in the report?

Who are the major players in the Lung Cancer Liquid Biopsy market?

What are the key trends in the Lung Cancer Liquid Biopsy market?

Major trends in the Lung Cancer Liquid Biopsy market include Technological Advancements In Blood-Based Lung Cancer Screening Drive Early Detection Efforts. For further insights on the Lung Cancer Liquid Biopsy market, request a sample here.